serum
SCC4; SCC9; SCC25; HN12; CAL27; HOK
-
proliferation (promotes); apoptosis (inhibits); TGF-beta/SMAD (other); MAPK (other); other pathway/process (other)
RT-qPCR; Clinical Sample Validation; Survival Analysis; Bioinformatics Analysis; Transfection; CCK8; TUNEL
High exosomal circ_0000199 is associated with lower overall survival and disease-free survival, and is an independent prognostic factor for OSCC.
circ_0000199 is up-regulated in circulating (serum) exosomes of OSCC patients and its high level predicts worse OS and DFS and higher recurrence/mortality. Functionally, circ_0000199 promotes OSCC cell proliferation and inhibits apoptosis, and is predicted to sponge miR-145-5p/miR-29b-3p to affect downstream targets (e.g., CPEB3, PAN2, RLIM, CFL2) and pathways including ECM-receptor interaction and TGF-beta signaling.
0.6304
Upregulation of circ_0000199 in circulating exosomes is associated with survival outcome in OSCC.
combined biological and clinical study